title: Miller Fisher syndrome.
abstract: A man aged 30 years presented to the emergency department (ED) with ataxia, areflexia, facial weakness, ophthalmoplegia, extremity weakness and back pain for 4 days. 4 days prior to attending the ED, the patient had suffered from diarrhoea for 2 weeks. The diagnosis of Miller Fisher syndrome was performed on the dual basis of clinical features in addition to an investigations report. Nerve conduction studies and anti-GQ1b IgG antibody analysis were requested. Once IgA deficiency was ruled out, the patient was started on intravenous immunoglobulin (400 mg/kg/day).
authors.affiliation: Department of Internal Medicine/Geriatrics, Forest Glen Medical Center, Silver Spring, Tennessee, USA.
authors.forename: Suresh Kumar
authors.initials: SK
authors.lastname: Gupta
authors.affiliation: Critical Care Medicine, Geisinger Medical Center, Danville, Pennsylvania, USA.
authors.forename: Kunal Kishor
authors.initials: KK
authors.lastname: Jha
authors.affiliation: Department of Internal Medicine, University of Sharjah College of Medicine, Sharjah, United Arab Emirates.
authors.forename: Mhd Diaa
authors.initials: MD
authors.lastname: Chalati
authors.affiliation: University of Jordan, Amman, Jordan.
authors.forename: Losan Tareq
authors.initials: LT
authors.lastname: Alashi
mesh_terms: D000328:Adult; D005732:Gangliosides / Q000276:immunology; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008297:Male; D019846:Miller Fisher Syndrome / Q000175:diagnosis / Q000628:therapy*
chemical_list: D005732:Gangliosides; D007074:Immunoglobulin G; D016756:Immunoglobulins, Intravenous; C039129:GQ1b ganglioside